1. Home
  2. COEP vs DTST Comparison

COEP vs DTST Comparison

Compare COEP & DTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • DTST
  • Stock Information
  • Founded
  • COEP 2017
  • DTST 2001
  • Country
  • COEP United States
  • DTST United States
  • Employees
  • COEP N/A
  • DTST N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • DTST EDP Services
  • Sector
  • COEP Health Care
  • DTST Technology
  • Exchange
  • COEP Nasdaq
  • DTST Nasdaq
  • Market Cap
  • COEP 32.4M
  • DTST 32.7M
  • IPO Year
  • COEP N/A
  • DTST N/A
  • Fundamental
  • Price
  • COEP $12.45
  • DTST $4.09
  • Analyst Decision
  • COEP
  • DTST
  • Analyst Count
  • COEP 0
  • DTST 0
  • Target Price
  • COEP N/A
  • DTST N/A
  • AVG Volume (30 Days)
  • COEP 111.8K
  • DTST 45.7K
  • Earning Date
  • COEP 03-25-2025
  • DTST 03-27-2025
  • Dividend Yield
  • COEP N/A
  • DTST N/A
  • EPS Growth
  • COEP N/A
  • DTST N/A
  • EPS
  • COEP N/A
  • DTST 0.02
  • Revenue
  • COEP N/A
  • DTST $25,143,911.00
  • Revenue This Year
  • COEP N/A
  • DTST $2.57
  • Revenue Next Year
  • COEP N/A
  • DTST $11.16
  • P/E Ratio
  • COEP N/A
  • DTST $203.17
  • Revenue Growth
  • COEP N/A
  • DTST 1.64
  • 52 Week Low
  • COEP $2.31
  • DTST $3.24
  • 52 Week High
  • COEP $13.70
  • DTST $8.00
  • Technical
  • Relative Strength Index (RSI)
  • COEP 63.21
  • DTST 42.03
  • Support Level
  • COEP $8.65
  • DTST $3.93
  • Resistance Level
  • COEP $12.95
  • DTST $4.25
  • Average True Range (ATR)
  • COEP 1.64
  • DTST 0.20
  • MACD
  • COEP -0.16
  • DTST -0.04
  • Stochastic Oscillator
  • COEP 75.25
  • DTST 20.78

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About DTST Data Storage Corporation

Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; Flagship Solutions, LLC and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.

Share on Social Networks: